Koninklijke Philips Net Income 2010-2025 | PHG

Koninklijke Philips annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Koninklijke Philips net income for the quarter ending March 31, 2025 was $0.080B, a 111.22% decline year-over-year.
  • Koninklijke Philips net income for the twelve months ending March 31, 2025 was $0.843B, a 357.52% decline year-over-year.
  • Koninklijke Philips annual net income for 2024 was $-0.76B, a 50.62% increase from 2023.
  • Koninklijke Philips annual net income for 2023 was $-0.504B, a 70.23% decline from 2022.
  • Koninklijke Philips annual net income for 2022 was $-1.694B, a 143.15% decline from 2021.
Koninklijke Philips Annual Net Income
(Millions of US $)
2024 $-760
2023 $-504
2022 $-1,694
2021 $3,927
2020 $1,356
2019 $1,307
2018 $1,287
2017 $1,873
2016 $1,602
2015 $716
2014 $552
2013 $1,553
2012 $291
2011 $-1,798
2010 $1,928
2009 $591
Koninklijke Philips Quarterly Net Income
(Millions of US $)
2025-03-31 $80
2024-09-30 $199
2024-06-30 $486
2023-06-30 $79
2023-03-31 $-714
2022-06-30 $-23
2021-06-30 $181
2020-06-30 $229
2019-06-30 $273
2018-06-30 $1
2017-06-30 $275
2016-12-31 $680
2016-09-30 $413
2016-06-30 $475
2016-03-31 $35
2015-12-31 $-51
2015-09-30 $355
2015-06-30 $301
2015-03-31 $112
2014-12-31 $169
2014-09-30 $-138
2014-06-30 $332
2014-03-31 $189
2013-12-31 $553
2013-09-30 $374
2013-06-30 $414
2013-03-31 $213
2012-12-31 $-482
2012-09-30 $221
2012-06-30 $204
2012-03-31 $326
2011-12-31 $-212
2011-09-30 $102
2011-06-30 $-1,934
2011-03-31 $198
2010-12-31 $630
2010-09-30 $676
2010-06-30 $331
2010-03-31 $277
2009-12-31 $384
2009-09-30 $254
2009-06-30 $64
2009-03-31 $-75
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.688B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $215.166B 25.24
Boston Scientific (BSX) United States $153.330B 38.39
Stryker (SYK) United States $148.630B 31.08
EssilorLuxottica (ESLOY) France $131.070B 0.00
Medtronic (MDT) Ireland $114.929B 16.29
Lonza Group Ag (LZAGY) Switzerland $49.764B 0.00
Haleon (HLN) United Kingdom $43.126B 24.62
ResMed (RMD) United States $37.818B 28.41
GE HealthCare Technologies (GEHC) United States $34.781B 16.51
Agilent Technologies (A) United States $32.381B 21.11
Terumo (TRUMY) Japan $23.911B 31.06
Insulet (PODD) United States $20.003B 78.52
Zimmer Biomet Holdings (ZBH) United States $18.437B 11.84
Baxter (BAX) United States $14.251B 10.64
Smith & Nephew SNATS (SNN) United Kingdom $13.214B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.705B 23.33
Lantheus Holdings (LNTH) United States $4.855B 12.25
Prestige Consumer Healthcare (PBH) United States $3.744B 16.73
Perrigo (PRGO) Ireland $3.706B 9.39
Haemonetics (HAE) United States $3.485B 15.88
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.307B 27.48
ICU Medical (ICUI) United States $3.014B 22.23
LeMaitre Vascular (LMAT) United States $1.802B 40.29
QuidelOrtho (QDEL) United States $1.721B 11.84
AtriCure (ATRC) United States $1.449B 0.00
Acuren (TIC) United States $1.408B 0.00
AdaptHealth (AHCO) United States $1.244B 12.63
Phibro Animal Health (PAHC) United States $1.192B 15.24
Green Thumb Industries (GTBIF) United States $1.190B 26.76
Neogen (NEOG) United States $1.029B 13.17
BioLife Solutions (BLFS) United States $0.996B 0.00
InMode (INMD) Israel $0.878B 8.85
Kestra Medical Technologies (KMTS) United States $0.816B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Tilray Brands (TLRY) Canada $0.625B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.619B 0.00
Owens & Minor (OMI) United States $0.599B 4.97
Evolus (EOLS) United States $0.593B 0.00
CeriBell (CBLL) United States $0.563B 0.00
Valneva SE (VALN) France $0.557B 0.00
Surmodics (SRDX) United States $0.432B 0.00
SNDL (SNDL) Canada $0.405B 0.00
Sanuwave Health (SNWV) United States $0.336B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
Capricor Therapeutics (CAPR) United States $0.314B 0.00
VAREX IMAGING (VREX) United States $0.298B 10.97
Quanterix (QTRX) United States $0.268B 0.00
Cresco Labs (CRLBF) United States $0.267B 0.00
Cerus (CERS) United States $0.260B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.63
Aurora Cannabis (ACB) Canada $0.255B 75.50
OraSure Technologies (OSUR) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.235B 10.68
Sanara MedTech (SMTI) United States $0.234B 0.00
Brainsway (BWAY) Israel $0.228B 60.45
Biote (BTMD) United States $0.220B 6.18
Canopy Growth (CGC) Canada $0.200B 0.00
High Tide (HITI) Canada $0.199B 0.00
Omeros (OMER) United States $0.197B 0.00
Verano Holdings (VRNOF) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.69
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Vireo Growth (VREOF) United States $0.149B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.120B 14.73
TerrAscend (TSNDF) Canada $0.110B 0.00
Jin Medical (ZJYL) China $0.103B 0.00
Fonar (FONR) United States $0.099B 12.80
MacroGenics (MGNX) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.091B 0.00
Veru (VERU) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.076B 0.00
Zynex (ZYXI) United States $0.070B 0.00
Agape ATP (ATPC) $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.055B 0.00
United-Guardian (UG) United States $0.042B 14.52
Nephros (NEPH) United States $0.039B 52.07
Rockwell Medical (RMTI) United States $0.038B 0.00
Modular Medical (MODD) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00